Northland Securities reissued their market perform rating on shares of XOS (NASDAQ:XOS – Free Report) in a research note issued to investors on Monday morning, MarketBeat reports. Northland Securities currently has a $5.00 price objective on the stock, down from their previous price objective of $9.00.
XOS has been the subject of a number of other reports. Roth Mkm assumed coverage on shares of XOS in a research report on Wednesday, October 23rd. They issued a “buy” rating and a $15.00 target price for the company. Roth Capital upgraded XOS to a “strong-buy” rating in a report on Wednesday, October 23rd. DA Davidson downgraded XOS from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $17.00 to $9.00 in a research report on Friday, August 16th. Northland Capmk upgraded XOS to a “strong-buy” rating in a report on Wednesday, October 2nd. Finally, Wedbush reduced their price target on XOS from $15.00 to $12.00 and set an “outperform” rating on the stock in a report on Thursday, August 15th. Three equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $10.25.
Get Our Latest Stock Analysis on XOS
XOS Stock Performance
XOS Company Profile
Xos, Inc designs, manufactures, and sells battery-electric commercial vehicles. The company provides class 5-6 medium duty rolling chassis, such as commercial stepvans and armored trucks; class 7-8 heavy duty chassis; and Xos product development. It offers Xos provides mix-use powertrain solutions for off-highway, industrial and other commercial equipment, and specialty vehicles, such as school buses, medical and dental clinics, blood donation vehicles, and mobile command vehicles.
Featured Articles
- Five stocks we like better than XOS
- Are Penny Stocks a Good Fit for Your Portfolio?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What is Forex and How Does it Work?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 3 Stocks to Consider Buying in October
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for XOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOS and related companies with MarketBeat.com's FREE daily email newsletter.